3 min readNew era in nasopharyngeal cancer: Toripalimab opens doors for immunotherapy.For decades, nasopharyngeal cancer patients facing recurrent or metastatic disease had limited treatment options.
4 min readOptimizing Care: Concurrent pembrolizumab with chemoradiation for locally advanced laryngeal cancerIn recent years, the fight against laryngeal cancer has made impressive strides, with cutting-edge treatment modalities altering
3 min readLenvatinib plus pembrolizumab improved survival outcomes in advanced endometrial cancerUterine cancer is the second most prevalent Gynecological cancer in the world and it has high incidence rates in developed countries.
